Nvidia Corp (NVDA) 30.49 $NVDA Advanced Micro Devices,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2015 at 2:26 PM

Nvidia Corp (NVDA) 30.49 $NVDA

Advanced Micro Devices, Inc. Wins Back Some Market Share From NVIDIA
Timothy Green, The Motley Fool - Motley Fool - Tue Nov 17, 9:45AM CST
During the second quarter of 2014, Advanced Micro Devices claimed a roughly 40% unit share of the graphics card market, with rival NVIDIA leading the market with a 60% share. While AMD was behind NVIDIA by a considerable margin, the company was...
AMD: 2.01 (+0.02), INTC: 32.82 (+0.72), NVDA: 30.49 (+0.09)

Netflix PT Lowered; Walgreens, Nvidia Upgraded
at Investor's Business Daily - Mon Nov 16, 3:44PM CST
Netflix (NFLX) got its price target lowered Monday, while Walt Disney Co. (DIS) was downgraded, and Walgreens Boots Alliance (WBA) and Tesla (TSLA) supplier Nvidia (NVDA) were upgraded Topeka Capital Markets trimmed its price target on Netflix to 142...
NFLX: 116.93 (+5.58), TSLA: 214.81 (+0.50), WBA: 83.01 (+1.17), WMT: 60.11 (+2.24), DIS: 117.03 (+1.11), RACE: 49.04 (-0.47), RAD: 7.77 (+0.03), TWX: 71.21 (+0.11), NVDA: 30.49 (+0.09)

Tesla Chipmaker Nvidia Scores Gaming Wins: Analyst
at Investor's Business Daily - Mon Nov 16, 12:52PM CST
Tesla (TSLA) chipmaker Nvidia (NVDA) scored PC gaming wins in 2015, with U.S. gamers shifting from Sony (SNE), Microsoft (MSFT) and Nintendo console systems to more online games, and took share from rival Advanced Micro Devices (AMD), an analyst...
AMBA: 52.52 (+1.67), TSLA: 214.81 (+0.50), IBM: 133.97 (+0.26), AMD: 2.01 (+0.02), QCOM: 53.18 (+0.41), SNE: 27.00 (-0.44), HMC: 32.52 (-0.09), INTC: 32.82 (+0.72), MSFT: 53.17 (-0.59), MBLY: 43.71 (+1.81), NVDA: 30.49 (+0.09)

Why NVIDIA Corp. Has Thrived in a "Post-PC" World
Ashraf Eassa, The Motley Fool - Motley Fool - Mon Nov 16, 12:35PM CST
NVIDIA's high-end GeForce GTX 980 Ti is one of the fastest gaming GPUs that the company sells today. Image source: NVIDIA. For quite a long time, many in the investment community seemed to lump graphics processor specialist NVIDIA along with...
AMD: 2.01 (+0.02), NVDA: 30.49 (+0.09)

3 Things NVIDIA Corporation Management Wants You to Know
Ashraf Eassa, The Motley Fool - Motley Fool - Mon Nov 16, 10:25AM CST
On Nov. 5, graphics chip specialist NVIDIA announced impressive financial results, delivering better-than-expected revenue and profit for its fiscal third quarter and guiding to a fiscal fourth quarter that was ahead of analyst consensus at the...
AMD: 2.01 (+0.02), NVDA: 30.49 (+0.09)

Nvidia, TripAdvisor, iShares Real Estate 50 ETF, SPDR Consumer Staples Select Sector ETF and Vanguard Materials ETF highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 8:30AM CST
Nvidia, TripAdvisor, iShares Real Estate 50 ETF, SPDR Consumer Staples Select Sector ETF and Vanguard Materials ETF highlighted as Zacks Bull and Bear of the Day
XLP: 48.79 (+0.14), TRIP: 78.48 (-0.07), FTY: 45.58 (+0.24), VAW: 97.77 (+0.38), NVDA: 30.49 (+0.09)

The Zacks Analyst Blog Highlights: NVIDIA, Paycom Software, Paylocity Holding, HubSpot and Five9
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 8:30AM CST
The Zacks Analyst Blog Highlights: NVIDIA, Paycom Software, Paylocity Holding, HubSpot and Five9
PCTY: 43.20 (+0.25), FIVN: 5.71 (+0.04), HUBS: 52.76 (+0.61), PAYC: 41.74 (+0.52), NVDA: 30.49 (+0.09)

Accelerator Use Surges in World's Top Supercomputers
Marketwired - Mon Nov 16, 8:01AM CST
TOP500 Highlights
NVDA: 30.49 (+0.09)

Nvidia (NVDA) Stock Rating Upgraded at Canaccord Genuity
at The Street - Mon Nov 16, 7:59AM CST
Nvidia (NVDA) stock was upgraded to "buy" from "hold" at Canaccord Genuity on Monday.
NVDA: 30.49 (+0.09)

Analysts' Actions -- Best Buy, Deere, Five Below, Mylan, Nvidia, Oracle
at The Street - Mon Nov 16, 7:55AM CST
Here are Monday's top research calls, including new views on Best Buy, Deere, Five Below, Mylan and more.
ZTS: 45.99 (+0.69), DE: 73.92 (-0.79), MYL: 51.31 (+1.31), LEAF: 49.32 (+0.22), BBY: 30.80 (-0.83), FIVE: 27.28 (-1.21), CASY: 114.20 (+1.32), ORCL: 38.36 (+0.24), LNT: 59.34 (-0.64), NVDA: 30.49 (+0.09)

Upgrade Alert for Nvidia (NVDA)
Comtex SmarTrend(R) - Mon Nov 16, 7:00AM CST
Nvidia (NASDAQ:NVDA) was upgraded from Hold to Buy at Canaccord Genuity today. The stock closed yesterday at $29.80 on volume of 7.3 million shares, below average daily volume of 10.2 million. Nvidia share prices have moved between a 52-week high of $31.94 and a 52-week low of $18.94 and closed yesterday at 57% above that low price at $29.80 per share. The 200-day and 50-day moving averages have moved 1.21% higher and 3.29% higher over the past week, respectively.
NVDA: 30.49 (+0.09)

Bull of the Day: Nvidia (NVDA)
Eric Dutram - ZACKS - Mon Nov 16, 6:16AM CST
Bull of the Day: Nvidia (NVDA)
NVDA: 30.49 (+0.09)

If You're in Your 40s, Consider Buying These Stocks
Andrés Cardenal, Matthew DiLallo, and Timothy Green, The Motley Fool - Motley Fool - Sun Nov 15, 6:00PM CST
It's generally a great time to invest when you're in your 40s. Most people are in their prime working years at that age, and you typically have a lot of time left until retirement. This means you can assume above-average volatility in exchange for...
TRIP: 78.48 (-0.07), EOG: 84.17 (-0.62), NVDA: 30.49 (+0.09)

Nvidia Set to Possibly Rebound After Yesterday's Selloff of 1.97%
Comtex SmarTrend(R) - Fri Nov 13, 5:11PM CST
Nvidia (NASDAQ:NVDA) traded in a range yesterday that spanned from a low of $29.65 to a high of $30.56. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $30.15 on volume of 7.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NVDA: 30.49 (+0.09)

SmarTrend Watching for Potential Rebound in Shares of Nvidia After 1.97% Loss
Comtex SmarTrend(R) - Fri Nov 13, 5:10PM CST
Nvidia (NASDAQ:NVDA) traded in a range yesterday that spanned from a low of $29.65 to a high of $30.56. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $30.15 on volume of 7.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NVDA: 30.49 (+0.09)

NVIDIA and 4 Great Momentum Tech Stocks for Your Portfolio
Zacks Equity Research - Zacks Investment Research - Fri Nov 13, 2:00PM CST
Shares of NVIDIA Corporation (NVDA) continue to rally following the better-than-expected third-quarter fiscal 2016 results and encouraging revenue guidance for the fourth quarter issued on Nov 5.
PCTY: 43.20 (+0.25), FIVN: 5.71 (+0.04), PAYC: 41.74 (+0.52), HUBS: 52.76 (+0.61), NVDA: 30.49 (+0.09)

Nvidia (NVDA) Crosses Pivot Point Support at $30.21
Comtex SmarTrend(R) - Fri Nov 13, 11:52AM CST
Nvidia (NASDAQ:NVDA) has opened bearishly below the pivot of $30.46 today and has reached the first level of support at $30.21. Analysts will be watching for a cross of the next downside pivot targets of $30.01 and $29.56.
NVDA: 30.49 (+0.09)

How NVIDIA Corporation Gained 15% in October
Anders Bylund, The Motley Fool - Motley Fool - Thu Nov 12, 6:48AM CST
NVDA data by YCharts . What: Shares of NVIDIA gained 15% in October, according to data from S&P Capital IQ . The catalyst for this market-beating autumnal jaunt? Merger rumors in NVIDIA's neck of the semiconductor woods, even tough this...
MXIM: 39.02 (-0.13), TXN: 57.41 (+0.53), ADI: 59.59 (+1.11), NVDA: 30.49 (+0.09)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chemours Faces Class Action Over Fraud Allegations

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Lunit, Summit Tackle Tumor Analysis with AI Platform

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...